Symptomatic Parkinson Disease
Also known as: Secondary parkinsonism, unspecified / Parkinsonism (disorder) / Symptomatic parkinsonism (disorder) / Secondary parkinsonism (disorder) / Parkinson Disease, Secondary / Secondary parkinsonism
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00190 | Carbidopa | A dopa decarboxylase inhibitor used in combination with levodopa for the symptomatic treatment of idiopathic Parkinson disease and other conditions associated with parkinsonian symptoms. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00190 | Carbidopa | Aromatic-L-amino-acid decarboxylase | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01136 | Carvedilol | 2 | Enrolling by Invitation | 1 |
| DB01136 | Carvedilol | 2 | Recruiting | 1 |
| DB01162 | Terazosin | 2 | Recruiting | 2 |